References

Zebenholzer K, Wober C, Vigl M, Wessely P, Wober-Bingol C. Facial pain and the second edition of the International Classification of Headache Disorders. Headache. 2006; 46:(2)259-263
Renton T. Pain Part 1: Introduction to pain. Dent Update. 2015; 42:109-124
Ravaghi V, Farrahi-Avval N, Locker D, Underwood M. Validation of the Persian short version of the Oral Health Impact Profile (OHIP-14). Oral Hlth Prevent Dent. 2010; 8:(3)229-235
Renton T, Yilmaz Z. Profiling of patients presenting with posttraumatic neuropathy of the trigeminal nerve. J Orofac Pain. 2011; 25:(4)333-344
Woda A, Tubert-Jeannin S, Bouhassira D, Attal N, Fleiter B, Goulet JP Towards a new taxonomy of idiopathic orofacial pain. Pain. 2005; 116:396-406
Affolter B, Thalhammer C, Aschwanden M, Glatz K, Tyndall A, Daikeler T. Difficult diagnosis and assessment of disease activity in giant cell arteritis: a report on two patients. Scand J Rheumatol. 2009; 38:(5)393-394
Pareja JA, Kruszewski P, Sjaastad O. SUNCT syndrome. Diagnosis morbi. Shortlasting Unilateral Neuralgiform headache attacks, with Conjunctival injection, Tearing and rhinorrhoea. Neurologia. 1997; 12:66-72
Balasubramaniam R, Klasser GD, Delcanho R. Trigeminal autonomic cephalalgias: a review and implications for dentistry. J Am Dent Assoc. 2008; 139:(12)1616-1624
Teixeira MJ, de Siqueira SR, Bor-Seng-Shu E. Glossopharyngeal neuralgia: neurosurgical treatment and differential diagnosis. Acta Neurochirurgica. 2008; 150:(5)471-475
Closmann JJ, Fielding CG, Pogrel MA. Prevention and management of trigeminal herpes zoster and postherpetic neuralgia. Gen Dent. 2008; 56:(6)563-566
Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial. Clin Drug Invest. 2009; 29:(4)231-241
London: National Institute for Health and Clinical Excellence; 2010
Renton T, Adey-Viscuso D, Meechan JG, Yilmaz Z. Trigeminal nerve injuries in relation to the local anaesthesia in mandibular injections. Br Dent J. 2010; 209:(9)
Renton T, Yilmaz Z. Managing iatrogenic trigeminal nerve injury: a case series and review of the literature. Int J Oral Maxillofac Surg. 2012; 41:(5)629-637
Birch R, Bonney G, Dowell J, Hollingdale J. Iatrogenic injuries of peripheral nerves. J Bone Joint Surg. 1991; 73:(2)280-282
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367:(9522)1618-1625
Nixdorf DR, Moana-Filho EJ, Law AS, McGuire LA, Hodges JS, John MT. Frequency of nonodontogenic pain after endodontic therapy: a systematic review and meta-analysis. J Endod. 2010; 36:(9)1494-1498
Lam NP, Donoff RB, Kaban LB, Dodson TB. Patient satisfaction after trigeminal nerve repair. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95:(5)538-543
MacDermid JC. Measurement of health outcomes following tendon and nerve repair. J Hand Therapy. 2005; 18:(2)297-312
Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpaa M, Jorum E EFNS Guidelines on Neuropathic Pain Assessment. Eur J Neurol. 2004; 11:(3)153-162
Haanpaa M, Attal N, Backonja M, Baron R, Bennett M, Bouhassira D NeuPSIG Guidelines on Neuropathic Pain Assessment. Pain. 2011; 152:(1)14-27
Mason DA. Lingual nerve damage following lower third molar surgery. Int J Oral Maxillofac Surg. 1988; 17:(5)290-294
Ngeow WC, Nair R. Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109:(3)e47-e50
Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin. 2004; 20:S21-S28
Mogil JS. Pain genetics: past, present and future. Trends Genet. 2012; 28:(6)258-266
Mongini F, Rota E, Evangelista A, Ciccone G, Milani C, Ugolini A Personality profiles and subjective perception of pain in head pain patients. Pain. 2009; 144:(1–2)125-129
Aggarwal VR, Lovell K, Peters S, Javidi H, Joughin A, Goldthorpe J. Psychosocial interventions for the management of chronic orofacial pain. Cochrane Database Syst Rev. 2011; (11)
Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings. 2010; 85:S3-14
, 5th edn. In: De Leeuw R, Klasser GD (eds). London: Quintessence Publishing; 2013
Tan T, Barry P, Reken S, Baker M. Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance. Br Med J. 2010; 340
Baad-Hansen L. Atypical odontalgia – pathophysiology and clinical management. J Oral Rehabil. 2008; 35:(1)1-11
Benoliel R, Kahn J, Eliav E. Peripheral painful traumatic trigeminal neuropathies. Oral Dis. 2012; 18:(4)317-332
List T, Leijon G, Svensson P. Somatosensory abnormalities in atypical odontalgia: a case-control study. Pain. 2008; 139:(2)333-341
Morley S, Williams A, Hussain S. Estimating the clinical effectiveness of cognitive behavioural therapy in the clinic: evaluation of a CBT informed pain management programme. Pain. 2008; 137:(3)670-680
Arch JJ, Eifert GH, Davies C, Plumb Vilardaga JC, Rose RD, Craske MG. Randomized clinical trial of cognitive behavioral therapy (CBT) versus acceptance and commitment therapy (ACT) for mixed anxiety disorders. J Consult Clin Psychol. 2012; 80:(5)750-765
Aggarwal VR, Tickle M, Javidi H, Peters S. Reviewing the evidence: can cognitive behavioral therapy improve outcomes for patients with chronic orofacial pain?. J Orofac Pain. 2010; 24:(2)163-171
Fledderus M, Bohlmeijer ET, Pieterse ME, Schreurs KM. Acceptance and commitment therapy as guided self-help for psychological distress and positive mental health: a randomized controlled trial. Psychol Med. 2012; 42:(3)485-495
Jurgens TP, Muller P, Seedorf H, Regelsberger J, May A. Occipital nerve block is effective in craniofacial neuralgias but not in idiopathic persistent facial pain. J Headache Pain. 2012; 13:(3)199-213
Yang HW, Huang YF. Treatment of persistent idiopathic facial pain (PIFP) with a low-level energy diode laser. Photomed Laser Surg. 2011; 29:(10)707-710

Pain part 5a: chronic (neuropathic) orofacial pain

From Volume 42, Issue 8, October 2015 | Pages 744-760

Authors

Tara Renton

BDS, MDSc, PhD

Professor of Oral Surgery, King's College London; Honorary Consultant in Oral Surgery, King's College Hospital NHS Foundation Trust and Guy's and St Thomas' NHS Foundation Trust, London

Articles by Tara Renton

Nadine Kahwaja

BDS, MJDS MSurgDent

Specialist Trainee, Oral Surgery, King's College London Dental Institute, Denmark Hill Campus, Bessemer Road, London SE5 9RS, UK

Articles by Nadine Kahwaja

Abstract

Neuropathic pain is a significant social and economic burden. Back pain, joint pain and headaches affect over 30% of the population. Chronic orofacial pain is a common condition and is difficult to diagnose and manage. This two-part paper aims to provide an overview of novel understanding of neuropathic pain, and furnish clinical teams with an update on the less common and less well-recognized chronic orofacial conditions. Headaches and temporomandibular disorders are the most common conditions and are covered in separate papers (6 and 10). Trigeminal neuralgia, burning mouth, and trigeminal autonomic cephalgias are also covered in separate papers (7, 8 and 9). The remaining conditions: post-traumatic neuropathy (nerve injury); and persistent idiopathic facial pain and atypical odontalgia are discussed in this and the following paper.

Clinical Relevance: Neuropathic pain, though rare, is a consequence of dental treatment. Nerve injury in relation to M3M surgery, dental implants, endodontics and local anaesthesia result in 70% of affected patients experiencing chronic neuropathic pain.

Article

Neuropathic pain is defined as ‘pain initiated or caused by a primary lesion or dysfunction in the nervous system’1 and is characterized by intense, chronic pain in the absence of any overt tissue damage or dysfunction. While chronic pain is an umbrella term referring to any type of neuropathic or dysfunctional (Table 1) pain affecting the body, there is evidence to suggest that neuropathic pain affecting the trigeminal nerve, which innervates most of the head and face tissues, is distinct from painful conditions seen elsewhere in the body.

Pain is normally caused by tissue damage of intense noxious stimuli, which activate high threshold receptors that may be pain specific (nociceptors) or polymodal receptors.2 Peripheral nervous system (PNS) neuropathic pain manifests in many ways, however, key signs include:

Mechanisms for the development and perpetuation of chronic pain are discussed earlier in this series.2 See figures illustrating overall central and peripheral mechanisms related to symptoms of neuropathic pain (Figure 1). Peripheral mechanisms related to persistent pain (Figure 2) and central mechanisms of neuropathic pain (Figure 3).

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available